Kiora Pharmaceuticals, Inc.

US$1.44As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:KPRXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (57.70%)
Div yield —
ROE (56.36%)
Biotechnology
Beta (5Y) (0.14)
PE TTM —
TSR TTM (37.66%)
Mkt cap US$9.163M
ROIC (30.73%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.47
2.41%
(35.16%)
Hold 10|4|8|3|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
25.16%
22.93%
7.10%
(3.59%)
Revenue$M
0.845
0.851
0.880
0.916
15.72%
14.07%
14.93%
13.67%
Peers (US$9.163M)
Cap (US$)
PE
9.286M
—
9.134M
—
9.170M
—
Capital
TTM
5Y
10Y
Leveragex
7.119
(0.118)
(0.060)
EBIT/Intx
1.713
0.328
0.440
Own earn%
6.16
(33.48)
(39.46)
Sh yield%
38.58
8.87
8.87
Owners
Insiders/Inst%
13.37
88.14
Short interest%
5.72
SBC / revenue%
2.74
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
23–28
$1 testx
0.1
Incr. ROIC%
1